Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

It has been suggested that Fusobacterium nucleatum (Fn) may differentially impact tumor immune responses according to microsatellite instability (MSI) status in colorectal cancers (CRCs). We aimed to reveal the detailed relationship between intratumoral Fn and immune microenvironmental features in MSI-high CRCs. A total of 126 MSI-high CRCs were subjected to analyses for intratumoral Fn DNA load using quantitative PCR and for densities of tumor-infiltrating immune cells, including CD3 T cells, CD4 T cells, CD8 T cells, FoxP3 T cells, CD68 macrophages, CD163 macrophages, and CD177 neutrophils, at invasive margin (IM) and center of tumor (CT) areas using computational image analysis of immunohistochemistry. Based on the Fn load, the 126 MSI-high CRCs were classified into Fn-high, -low, and -negative subgroups. The Fn-high subset of MSI-high CRCs was significantly correlated with larger tumor size and advanced invasion depth (p = 0.017 and p = 0.034, respectively). Compared with the Fn-low/negative subgroup, Fn-high tumors demonstrated significantly lower density of FoxP3 cells in both IM and CT areas (p = 0.002 and p = 0.003, respectively). Additionally, Fn-high was significantly associated with elevated CD163 cell to CD68 cell ratio in only CT areas of MSI-high CRCs (p = 0.028). In conclusion, the Fn-enriched subset of MSI-high CRCs is characterized by increased tumor growth and invasion and distinct immune microenvironmental features, including decreased FoxP3 T cells throughout the tumor and increased proportion of M2-polarized macrophages in the tumor center. These findings collectively support that Fn may be linked to pro-tumoral immune responses in MSI-high CRCs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10991456PMC
http://dx.doi.org/10.1007/s00262-020-02657-xDOI Listing

Publication Analysis

Top Keywords

msi-high crcs
28
immune microenvironmental
12
microenvironmental features
12
foxp3 cells
12
colorectal cancers
8
fusobacterium nucleatum
8
immune responses
8
crcs
8
126 msi-high
8
subset msi-high
8

Similar Publications

Objective: Recent advancements in genome analyses, including the BRAF gene and mismatch repair (MMR) gene/microsatellite instability (MSI), have revealed the biological diversity of colorectal cancer (CRC). BRAF-mutated CRC has a poor prognosis; however, cases exhibiting deficient MMR (dMMR)/MSI-high (MSI-H) and BRAF gene mutations have demonstrated significant prognostic improvement following recent immune checkpoint inhibitor therapy. Therefore, the diagnosis of these subtypes is important.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with multiple colorectal cancers (CRC) show distinct clinical characteristics, including a higher prevalence of strong family history and right-sided colon cancer compared to those with solitary CRC.
  • A study analyzed 1,272 patients, revealing that 7.8% had multiple CRCs, with varying outcomes for synchronous and metachronous cases, particularly in terms of operation time and blood loss.
  • Overall, minimally invasive surgery (MIS) is feasible for treating multiple CRCs, and recent advancements like indocyanine green fluorescence imaging have improved postoperative outcomes, including reducing anastomotic leakage rates.
View Article and Find Full Text PDF

Background: Microsatellite instability (MSI) and mismatch repair (MMR) detection is valuable in assessing prognosis and treatment options. However, the conventional detection methods such as immunohistochemistry (IHC) are limited by not fully consistent results as well as a long turnaround time. TrueMark™ MSI Assay is a novel solution for MSI analysis, but lack of research support in the Chinese colorectal cancer (CRC) patients.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is a common cancer in younger adults. In patients undergoing liver resection with RAS-altered CRCs, there is evidence suggesting younger patients have worse outcomes than older patients. To explain this pattern, differences in associations between RAS status and other cancer-related biomarkers in tumors from younger versus older patients with CRC were evaluated in a cohort of 925 patients with CRC, 277 (30.

View Article and Find Full Text PDF

Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers.

Ann Diagn Pathol

August 2024

Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address:

CDX2 and SATB2 are often used as biomarkers for identification of colorectal origin in primary or metastatic adenocarcinomas. Loss of CDX2 or SATB2 expression has been associated with poor prognosis in patients with colorectal cancer (CRC). However, little is known regarding clinicopathological features, including prognosis, of CRCs with concomitant loss of CDX2 and SATB2.

View Article and Find Full Text PDF